Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's reply

J Clin Epidemiol. 2022 May:145:183-184. doi: 10.1016/j.jclinepi.2021.12.021. Epub 2021 Dec 20.

¹ Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health at Charité, QUEST Center for Responsible Research, Germany. Electronic address: boesen.kim@gmail.com.
² Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
³ Institute for Scientific Freedom, Copenhagen, Denmark.

No abstract available

Keywords: ADHD; Clinical trials; Drug authorizations; Methylphenidate; Psychiatry; Regulatory agencies.

Publication types